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Abstract Despite early revascularization, remodeling
and dysfunction of the left ventricle (LV) after acute
myocardial infarction (AMI) remain important thera-
peutic targets. Intermittent pacing therapy (IPT) of the
LV can limit infarct size, when applied during early
reperfusion. However, the effects of IPT on post-AMI
LV remodeling and infarct healing are unknown. We
therefore investigated the effects of IPT on global LV
remodeling and infarct geometry in swine with a 3-day
old AMI. For this purpose, fifteen pigs underwent 2 h
ligation of the left circumflex coronary artery followed
by reperfusion. An epicardial pacing lead was implanted
in the peri-infarct zone. After three days, global LV
remodeling and infarct geometry were assessed using
magnetic resonance imaging (MRI). Animals were
stratified into MI control and IPT groups. Thirty-five
days post-AMI, follow-up MRI was obtained and
myofibroblast content, markers of extracellular matrix
(ECM) turnover and Wnt/frizzled signaling in infarct
and non-infarct control tissue were studied. Results
showed that IPT had no significant effect on global LV
remodeling, function or infarct mass, but modulated
infarct healing. In MI control pigs, infarct mass reduc-
tion was principally due to a 26.2 ± 4.4% reduction in
infarct thickness (P B 0.05), whereas in IPT pigs it was
mainly due to a 35.7 ± 4.5% decrease in the number of
infarct segments (P B 0.05), with no significant change
in infarct thickness. Myofibroblast content of the infarct
zone was higher in IPT (10.9 ± 2.1%) compared to MI
control (5.4 ± 1.6%; P B 0.05). Higher myofibroblast
presence did not coincide with alterations in expression
of genes involved in ECM turnover or Wnt/frizzled
signaling at 5 weeks follow-up. Taken together, IPT
limited infarct expansion and altered infarct composi-
tion, showing that IPT influences remodeling of the
infarct zone, likely by increasing regional myofibroblast
content.
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Introduction
The prevalence of heart failure continues to rise worldwide
[6, 31]. An important risk factor for heart failure is left-
ventricular (LV) remodeling following acute myocardial
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infarction (AMI), with infarct size as its principal deter-
minant [6, 14, 28]. Despite advances in the treatment of
AMI and subsequent cardiac remodeling, a need exists for
novel adjunctive therapies [5]. Current strategies under
investigation for cardioprotection include pharmacological
agents or application of brief mechanical interruptions of
coronary blood flow either before ischemia or during early
reperfusion to protect the myocardium by reducing infarct
size [9, 12]. In addition, evidence from experimental
studies shows that intermittent pacing therapy (IPT) is
capable of limiting infarct size not only when applied prior
to ischemia [21, 46] but also when applied during early
reperfusion [1, 3, 45], resulting in a trend towards blunting
of subsequent LV remodeling [2]. Importantly, a recent
clinical study confirmed pacing therapy to be effective at
reducing infarct size in patients, when started at reperfusion
[47].
Presently, it remains incompletely understood whether
IPT is capable of limiting LV remodeling independent of
its protection against acute myocardial necrosis, i.e.,
when started a few days after reperfusion. Consequently,
the aim of the present study was to investigate the
effects of dyssynchronous IPT of the left ventricle
(IPTVVI), when started in the sub-acute phase after
reperfusion, in a large animal model of transmural
reperfused AMI produced by a transient coronary artery
occlusion (CAO). For this purpose, swine were subjected
to a 120-min CAO followed by reperfusion, three days
after which they underwent cine-MRI and delayed
enhancement MRI (DE-MRI) to assess global LV
remodeling and function as well as infarct geometry.
Subsequently animals received IPTVVI (3 9 5 min
b.i.d.) throughout the five weeks post-AMI.
Materials and methods
Experiments were performed in thirty-six 5–6-month-old
Yorkshire x Landrace pigs of either sex and were con-
ducted in compliance with the ‘‘Guide for the Care and use
of Laboratory Animals’’ and after written approval of the
Animal Care Committee of the Erasmus MC.
Acute effects of IPTAAI and IPTVVI on LV
function
In four chronically instrumented swinewe assessed safety and
proper functioning of the pacemakers by investigating the
acute hemodynamic responses to intermittent dyssynchronous
pacing of the left ventricle (IPTVVI) in comparison with
intermittent synchronous atrial pacing (IPTAAI). See Sup-
plemental Methods and Results for detailed protocol and
results.
Effects of chronic IPTVVI on global LV
and regional infarct remodeling
Surgery
Swine (n = 27) were sedated [ketamine 20 mg/kg intra-
muscular (IM); midazolam, 1 mg/kg, IM; atropine 1 mg,
IM], anesthetized [thiopental sodium, 15 mg/kg, intra-
venous (IV)] and intubated. Anesthesia was maintained
with fentanyl (20 lg/kg/h, IV) until LCx occlusion, fol-
lowed by isoflurane (1–2% v/v). Antibiotic prophylaxis
consisted of procaine benzylpenicillin (20 mg/kg, IM) and
dihydrostreptomycin (25 mg/kg, IM). Following thoraco-
tomy via the third left intercostal space, a polyvinylchlo-
ride catheter was placed in the aortic arch, the pericardium
was opened and the proximal LCx was dissected. A
unipolar epicardial lead was actively fixed in the antici-
pated anterior infarct border zone, followed by 2 h of LCx
occlusion. The pericardium and chest were closed and the
animals were allowed to recover, receiving analgesia
(buprenorphine, 0.01 mg/kg/day, IM) for 48 h. Pacemakers
were interrogated weekly. Six swine died during the AMI
procedure; two swine died during the first 24 h post-AMI;
one swine died during transportation to the MRI at 3 days.
Experimental protocol
Three days after AMI, cardiac MRI was performed. Swine
were sedated and intubated as described above. Mechanical
ventilation and peri-imaging breath holds were performed
using a mobile ventilator. During MRI, anesthesia was
maintained with fentanyl (20 lg/kg/h, IV) and thiopental
sodium (100 mg bolus). Muscle relaxation was achieved
using pancuronium bromide (2–4 mg, IV). Post-imaging,
animals received antibiotic prophylaxis as described above
and were allowed to recover. Then, animals were ran-
domized to either MI control or IPTVVI and pacemakers
remained switched off (MI control) or were started
(IPTVVI). Importantly, none of the remaining 18 swine
died prematurely after stratification into MI control
(n = 11) or IPTVVI (n = 7) groups. The IPTVVI pacing
protocol was applied every 12 h (6 am and 6 pm), con-
sisting of three times 5-min of pacing at 30 beats/min
above sinus rhythm (AV-delay 10 ms) separated by 5-min
of normal sinus rhythm. Post hoc analysis of pacemaker
readouts could not confirm proper pacing in one IPTVVI
animal, whereas in the MI control group two animals
received unplanned indiscriminate pacing. Consequently,
for final analysis six swine were included in the IPTVVI
group and nine swine were included in the MI control
group. At one and five weeks post-AMI arterial blood
samples were collected in subsets of animals (n = 5 per
group). Five weeks after onset of treatment, cardiac MRI
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measurements were repeated and animals were killed for
histological and molecular analysis of the infarct zone.
Cardiac magnetic resonance imaging
Cardiac MRI was performed and analyzed on a 3T scanner
as described before [4, 38]. Global and regional cardiac
function and infarct geometry were assessed at baseline
(3 days post-AMI), i.e., before treatment and at 5 weeks
follow-up (see Supplemental Methods and Results).
Biomarkers
Arterial blood samples were collected 1 and 5 weeks post-
AMI in EDTA tubes (n = 5) and plasma was stored at
-80 C. Markers of inflammation (TNFa) and extracellu-
lar matrix turnover (MMP-9, TIMP-1) were quantified
using dedicated porcine enzyme-linked immunosorbent
assays (ELISA) according to manufacturer’s instructions
(see Supplemental Methods and Results).
Histology
At 5 weeks follow-up, transverse sections of infarct tissue
were fixed in 4% formaldehyde and embedded in paraffin.
To quantify myofibroblasts in the infarct area, sections
were stained for alpha smooth muscle actin (aSMA; [44];
see Supplemental Methods and Results). Data were
expressed as myofibroblast area/total tissue area (%). In
addition, lateral wall myocardial tissue of five additional
weight-matched healthy swine was quantified for myofi-
broblast content.
To quantify total collagen content and discriminate
collagen fiber type in the infarct area, sections were stained
with 0.1% picrosirius red in saturated picric acid (n = 6
per group). Collagen content in the infarct region was
expressed as stained area/total infarct area (%) using bright
field images (four photos per animal). Collagen fiber types
were assessed by circular polarizing microscopy in which
five polarizing colors were discerned; red (type I collagen,
mature), orange, yellow, green, and teal (type III collagen,
immature) to discriminate between mature and immature
collagen and were expressed as polarized area of inter-
est/total polarized area (%).
RT-PCR
Infarct tissue from all animals as well as normal myo-
cardium of the weight-matched non-MI control group
(n = 5) was homogenized and RNA was isolated. The
isolated RNA was assessed for concentration and purity
(A260/A280 ratio), and reverse-transcribed into cDNA (see
Supplemental Methods and Results). The expression of 21
genes related to myofibroblast presence, regulation or dif-
ferentiation, were quantified as well as seven genes
involved in extracellular matrix turnover (see Table 2 and
Supplemental Methods and Results). Quantification of
gene expression was performed using the comparative Ct
(DCt) method and results are expressed as ratios to the
housekeeping gene cyclophilin.
Statistical analysis
All data are expressed as mean ± SEM. Data were ana-
lyzed using two-way (time 9 treatment) RM-ANOVA
followed by post hoc testing, when appropriate, or within
treatment group differences with paired t testing, and
between treatment group differences with unpaired t testing
(SPSS 15.0, IBM, Armonk, NY, USA). One-way ANOVA
testing with Fisher’s least significant difference correction
(LSD) was used to analyze gene expression data. P B 0.05
(two-tailed) was considered statistically significant.
Results
Acute effects of IPTAAI and IPTVVI on LV
function
Safety and proper functioning of ventricular pacing pro-
tocols were ascertained in four pigs as evidenced by the
absence of ventricular arrhythmias and a programmed
increase in heart rate of 30 beats/min (see Supplemental
Methods and Results and Supplemental Figure 1 for
details).
Effects of chronic IPTVVI on global LV
and regional infarct remodeling
Table 1 summarizes global LV anatomy, function and
infarct geometry data at baseline and at follow-up. In MI
control animals, two hours of occlusion of the LCx resulted
in AMI that comprised 31 ± 2% of the LV. Already at
3-day post-AMI, LV end-diastolic volume (EDV,
80 ± 3 ml) and end-systolic volume (ESV, 54 ± 3 ml)
were larger as compared to EDV (68 ± 3 ml) and ESV
(30 ± 2 ml) in a historical control group of healthy ado-
lescent swine of similar age [30]. MI resulted in a
depressed ejection fraction (EF) of 33 ± 2%, compared to
55 ± 3% in normal healthy swine [30]. During the
5 weeks follow-up, total LV mass did not change, as the
increase in mass of the remote myocardium was balanced
by an equivalent decrease in infarct mass (Table 1). EDV
and ESV further increased to 113 ± 5 and 68 ± 3 ml,
respectively, with EF tending to slightly recover from
33 ± 2 to 40 ± 2% (P = 0.06). The increase in EDV over
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time in swine with MI was in part attributable to physio-
logical growth of the heart, as EDV in healthy swine
showed a modest increase from 68 ± 3 to 91 ± 6 ml [30].
In contrast to the increase in ESV over time in swine with
MI (from 54 ± 3 to 68 ± 3 ml), there was a negligible
increase in ESV in healthy swine (from 30 ± 2 to
32 ± 3 ml), associated with an increase in EF from 55 ± 3
to 64 ± 3% [30]. These findings indicate that MI resulted
in LV remodeling and dysfunction that was already
observed early at 3 days and was sustained throughout the
5 weeks follow-up period.
Global LV and infarct geometry parameters showed no
significant differences between IPTVVI and MI control
(Table 1) at the 3-day post-AMI baseline. Moreover, the
changes in global LV anatomy and function during
5 weeks of follow-up were not different between IPTVVI
and MI control. However, infarct geometry responded
markedly to IPTVVI (Table 1; Fig. 1). In MI control ani-
mals, infarct mass decreased over time as a result of a
significant decrease in infarct thickness with no significant
changes in infarct length or circumference, and no changes
Table 1 Global LV function and infarct geometry
Post-MI
3 days BL 37 days FU
Global LV anatomy and function
Body weight (kg)
MI control 29 ± 0 38 ± 1*
IPT 28 ± 1 37 ± 1*
LV mass (g)
MI control 56 ± 1 58 ± 1
IPT 55 ± 2 55 ± 1
Heart rate (bpm)
MI control 93 ± 3 80 ± 6
IPT 100 ± 6 78 ± 11
End-diastolic volume (ml)
MI control 80 ± 3 113 ± 5*
IPT 81 ± 2 110 ± 8*
End-systolic volume (ml)
MI control 54 ± 3 68 ± 3*
IPT 53 ± 2 67 ± 8
Stroke volume (ml)
MI control 27 ± 2 45 ± 4*
IPT 28 ± 2 43 ± 3*
Ejection fraction (%)
MI control 33 ± 2 40 ± 2**
IPT 35 ± 3 40 ± 3*
Infarct geometry
Remote LV mass (g)
MI control 39 ± 1 47 ± 1*
IPT 38 ± 1 46 ± 1*
Infarct mass (g)
MI control 17.6 ± 1.4 11.7 ± 0.8*
IPT 17.1 ± 1.2 9.3 ± 0.9*,
Infarct size (% LV)
MI control 31 ± 2 20 ± 1*
IPT 31 ± 2 17 ± 2*
Infarct thickness (mm)
MI control 6.2 ± 0.2 4.5 ± 0.2*
IPT 5.9 ± 0.2 4.9 ± 0.3
Infarct length (#slices)
MI control 7.8 ± 0.6 8.3 ± 0.6
IPT 8.8 ± 0.3 8.0 ± 0.5*
Infarct length (mm)
MI control 47 ± 4 50 ± 4
IPT 53 ± 2 48 ± 3*,
Infarct circumference (#segments)
MI control 13.5 ± 0.8 12.0 ± 1.1
IPT 13.6 ± 1.6 9.4 ± 1.3*,
Infarct circumference (mm)
MI control 62 ± 3 65 ± 6
IPT 61 ± 5 52 ± 5
Table 1 continued
Post-MI
3 days BL 37 days FU
Total # infarcted segments
MI control 73 ± 8 71 ± 9
IPT 90 ± 9 58 ± 8*,
Data are mean ± SEM; MI control, n = 9; IPT, n = 6
BL baseline, FU follow-up, LV left ventricle
* P\ 0.05, vs. corresponding BL
** P\ 0.10, vs. corresponding BL
 P\ 0.05,  P\ 0.10, change by IPT vs. change in control
Fig. 1 Effect of IPTVVI on infarct geometry. Percent changes in
infarct geometry from 3 days baseline values at 5-week follow-up in
eight MI control (white bars) and six IPTVVI (gray bars) swine.
Shown are changes in infarct mass, infarct thickness, total number of
infarcted segments, number of infarcted slices, and average circum-
ferential infarct length. Data are mean ± SEM; *P B 0.05 vs.
corresponding BL; P B 0.05, P B 0.10, vs. change in MI control
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in the total number of infarcted segments. In contrast, in
IPTVVI animals, the reduction in infarct mass was pri-
marily due to a decrease in total number of infarcted seg-
ments (comprising reductions in both infarct length and
circumference), with no significant decrease in infarct
thickness. The latter could have played a role in preventing
the reduction in infarct mass from reaching statistical sig-
nificance compared to MI control group (P = 0.07; Fig. 1).
Infarct composition
Histological quantification of aSMA positive cells in the
infarct region showed a significantly higher amount of
myofibroblasts in the infarct area in IPTVVI
(10.9 ± 2.1%) than in MI control (5.4 ± 1.6%) swine
(Fig. 2). aSMA quantification of referent control tissue
(excluding the coronary microvasculature) equaled zero
and confirmed the absence of myofibroblasts in healthy
myocardial tissue. mRNA-expression data for aSMA
between IPTVVI and MI control confirmed the IPTVVI-
induced increase in aSMA in histological findings
(P = 0.04, see Table 2).
Canonical Wnt/frizzled signaling is activated upon injury
including myocardial infarction [13, 50]. Indeed, the
increased myofibroblast presence in infarcted tissue as
compared to non-MI tissue was accompanied by activation
of the Wnt/frizzled signaling, as evidenced by increased
presence of the Fzd2 receptor and its co-receptor LRP5.
However, downstream targets of canonical Wnt/frizzled
signaling (axis inhibition protein 2 (Axin), adenomatous
polyposis coli (APC) and b-catenin) were not altered in
infarcted tissue as compared to non-MI tissue. The inflam-
matory markers transforming growth factor b1 (TGFb1) and
TGFb2 were also not altered, while TGFb3 was increased in
MI as compared to non-MI tissue, and its receptors TGFb1R
and TGFb2R were decreased. Overall, TGFb-signaling
appeared to be reduced in MI as compared to non-MI tissue,
as evidenced by a decrease in PAI1. However, IPTVVI had
no effect on either Wnt/frizzled or TGFb-signaling
(Table 2), while circulating levels of TNFa were also not
different between IPT and MI control animals (Fig. 3).
Consistent with the role of myofibroblasts in extracel-
lular matrix (ECM) production and turnover, Col1a1-ex-
pression at follow-up was significantly increased in
IPTVVI animals compared to MI control (P = 0.04), while
Col3a1 expression was elevated in both MI control and IPT
animals (Table 2).
Histological quantification of total collagen content
showed no differences between MI control and IPTVVI
infarct collagen content at 5 weeks follow-up (73 ± 3 vs.
78 ± 4%, respectively, P = 0.34). Furthermore, collagen
composition, expressed as the percentage type I collagen
fiber (red, mature; 52 ± 7 vs. 65 ± 6%, P = 0.22) and
type III collagen (teal, immature; 10 ± 2 vs. 7 ± 1%,
respectively, P = 0.12) were not different between groups
(See Supplemental Methods and Results for individual
data).
Circulating plasma levels of extracellular matrix turn-
over (MMP-9 and TIMP-1), measured at 1 and 5 weeks
post-AMI, did not differ significantly between treatment
groups (Fig. 3), although there was a trend towards an
increase in TIMP-1 expression in the infarcted area in
IPTVVI vs. MI control (Table 2, P = 0.09, two-tailed),
that together with the increased Col1a1 expression may
reflect increased ECM turnover.
Discussion
The present study is the first to investigate the effects of
dyssynchronous intermittent ventricular pacing (IPTVVI),
initiated three days after acute myocardial infarction (AMI)
and continued for 5 weeks, on global and regional LV
remodeling and infarct geometry in a clinically relevant
large animal model. The major findings were that (1)
IPTVVI had no effect on global LV remodeling or func-
tion, but (2) had a marked effect on infarct remodeling by
decreasing the number of infarcted segments without
Fig. 2 IPTVVI increases
myofibroblast presence in the
infarct region. Left panel aSMA
stained infarct tissue of two MI
control and two IPTVVI swine
(magnification 920). Brown
staining indicates
myofibroblasts. Right panel
percent aSMA-positive cells in
infarct tissue from eight MI
control (white bar) and six
IPTVVI (gray bar) swine. Data
are mean ± SEM; *P B 0.05
vs. MI control
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changing infarct thickness. (3) Additionally, IPTVVI
increased myofibroblast content in the infarcted area, (4)
without changing circulating markers of inflammation and
extracellular matrix turnover. These findings provide evi-
dence that intermittent electrical stimulation of the left
ventricle may represent a novel means to modulate scar
remodeling after MI.
IPT in AMI and post-AMI remodeling
Several studies in swine [21] and rabbits [45, 46] have
shown that pretreatment with ventricular, but not atrial
[27], pacing is capable of limiting myocardial infarct size.
Subsequent studies have demonstrated that not only pre-
conditioning [21, 45, 46], but also postconditioning with
brief periods of ventricular pacing in the early reperfusion
phase [1–3, 45] can limit myocardial infarct size. More-
over, the effects of this early protection against myocardial
necrosis were sustained over a six week period, resulting in
a trend towards blunted LV remodeling and improved LV
function [2]. The present study is the first to investigate the
effects of prolonged IPT on infarct remodeling, indepen-
dent of its protection against acute myocardial necrosis in a
preclinical animal model. The results of this study clearly
demonstrate that IPTVVI started 3 days after reperfusion,
at a time when necrosis can no longer be affected, signif-
icantly influenced remodeling of the infarct region.
Early studies in humans in the pre-thrombolysis era,
reported disproportionate thinning and stretching of the
infarcted segment [18, 48, 49]. Recent post-thrombolysis
studies in humans with reperfused AMI confirm that
regional myocardial wall thinning represents (transmural)
myocardial infarction [35]. Furthermore, limited scar bur-
den is associated with improved contractility [35] and
blunted remodeling [28], whereas rupture-prone cardiac
aneurysms are the consequence of continued ventricular
wall thinning [22]. Also, late dilatation of the LV after
primary percutaneous intervention remains of clinical sig-
nificance [37] and may represent a potential target of
IPTVVI. Thus, the IPTVVI-induced alteration of infarct
geometry may mitigate the sequence of events leading to
ventricular wall thinning and limit LV remodeling.
Although significant changes in infarct geometry and
composition were observed in the present study, these
alterations did not yet translate into favorable global LV
remodeling at 5 weeks follow-up. This finding, which is
similar to previous observations with cell-therapy studies
in swine [29], as well as humans [19], with AMI, suggests
that more pronounced changes in infarct geometry are
required to translate into benefits at the global LV level.
Table 2 Expression of genes related to myofibroblasts and extra-
cellular matrix biology
Non-MI control MI control IPT
Myofibroblast presence, regulation and differentiation
aSMA 0.5 ± 0.1 0.7 ± 0.1 1.2 ± 0.3*,
Vimentin 2.7 ± 0.6 1.7 ± 0.5 1.6 ± 0.4
Desmin 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.1
SPARC 0.5 ± 0.1 1.6 ± 0.5 1.9 ± 0.7**
Tenascin-
C
0.1 ± 0.1 1.5 ± 0.9 0.6 ± 0.2*
VEGF-A 1.3 ± 0.4 0.6 ± 0.1** 0.6 ± 0.3**
b-Catenin 0.7 ± 0.3 0.6 ± 0.1 0.4 ± 0.1
TGFb1 0.8 ± 0.3 0.8 ± 0.1 0.6 ± 0.1
TGFb2 2.7 ± 1.0 1.8 ± 0.6 1.4 ± 0.1
TGFb3 0.2 ± 0.1 6.1 ± 2.2** 5.2 ± 1.8
TGFb1R 3.3 ± 1.3 1.1 ± 0.2* 0.9 ± 0.1*
TGFb2R 1.7 ± 0.5 0.8 ± 0.1* 0.7 ± 0.1*
Fzd2 0.4 ± 0.1 1.5 ± 0.4** 1.7 ± 0.3*
Fzd4 0.9 ± 0.2 1.3 ± 0.3 0.9 ± 0.2
LRP5 0.2 ± 0.1 0.8 ± 0.2* 0.5 ± 0.2
LRP6 1.1 ± 0.3 0.7 ± 0.1 0.7 ± 0.1
LOX 2.1 ± 0.6 2.0 ± 0.7 3.6 ± 0.7
APC 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.1
Axin2 3.1 ± 1.2 3.6 ± 1.2 3.5 ± 1.0
ID1 0.2 ± 0.1 0.6 ± 0.2 0.7 ± 0.2
PAI1 2.6 ± 1.2 1.0 ± 0.2** 0.6 ± 0.2*
Extracellular matrix composition and turnover
Col1a1 0.9 ± 0.2 2.1 ± 0.7 4.7 ± 1.3*,
Col1a2 2.7 ± 0.7 1.9 ± 0.6 3.5 ± 1.3
Col3a1 0.3 ± 0.1 1.7 ± 0.5** 2.0 ± 0.6*
MMP-2 1.4 ± 0.4 1.7 ± 0.5 2.5 ± 0.7
MMP-9 1.9 ± 0.6 4.5 ± 1.6 4.5 ± 1.5
TIMP-1 0.1 ± 0.1 1.5 ± 0.4 3.4 ± 1.5*,
CTGF 1.6 ± 1.3 1.8 ± 0.5 0.9 ± 0.3
Data are presented as mean ± SEM and expressed as ratios to
housekeeping gene cyclophilin; MI control: n = 9; IPT: n = 6, non-
MI control: n = 5
APC adenomatous polyposis coli, Axin axis inhibition protein, aSMA
alpha smooth muscle actin, Col collagen, CTGF connective tissue
growth factor, Fzd frizzled, ID inhibitor of DNA binding, LOX lysyl
oxidase, LRP low-density lipoprotein receptor-related protein, MMP
matrix metalloproteinase, PAI plasminogen activator inhibitor, RT-
qPCR reverse transcriptase quantitative polymerase chain reaction,
SPARC secreted protein acidic and rich in cysteine, TGF transforming
growth factor, TIMP tissue inhibitor of metalloproteinases, VEGF-A
vascular endothelial growth factor A
* P B 0.05 vs. non-MI control
** P B 0.10 vs. non-MI control
 P B 0.05 IPT vs. corresponding MI control
 P B 0.10 IPT vs. corresponding MI control
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This may also explain why a recent clinical study on peri-
infarct zone pacing after AMI (PRomPT Trial) reported no
difference in LV function or geometry at 18-month follow-
up [39]. A limitation of the present study is that we
investigated only a single algorithm of pacing therapy, so
that we cannot exclude that other algorithms or pacing
protocols may produce larger regional effects that do
translate into global LV improvements [3]. Clearly, future
studies, are necessary to optimize the onset, timing, dura-
tion and mode of pacing therapy.
IPT and infarct geometry: role of myofibroblasts
The infarct zone is increasingly being appreciated as an
area with relevant biological activity and therapeutic
potential [8, 40]. Cardiac fibroblasts, including the active
collagen-secreting myofibroblasts, are the dominant cell
type in the infarct region and are recognized as essential in
infarct remodeling [7, 20, 41, 43]. Myofibroblasts typically
appear in the infarct area at 4–5 days after AMI, reach a
peak at 1–2 weeks and continue to reside up to at least
4 weeks [10] and possibly months to years [43]. In the
present study, IPTVVI, started at three days post-AMI,
increased myofibroblast numbers in the infarct zone sig-
nificantly. Myofibroblasts could have contributed to the
geometric changes in the infarct region produced by
IPTVVI in several ways. First, in the infarcted myo-
cardium, myofibroblasts are responsible for collagen turn-
over thus contributing to the delicate balance between
ECM synthesis and degradation [43]. Consistent with a role
of myofibroblasts in ECM synthesis, Col1a1 expression
was increased by IPTVVI. Moreover, a trend towards
increased expression of TIMP-1 was found in infarcts of
IPTVVI animals (P = 0.09) compared to MI control,
which is consistent with the observations of Mukherjee
et al. [32] that TIMP-1 co-localizes with myofibroblasts
within the infarct zone. Although the increased Col1a1
expression and the trend towards an increase in TIMP-1 did
not translate into an increase in collagen as measured with
histology, it is plausible that myofibroblasts, a rich source
of bioactive molecules [34], modulated infarct geometry by
affecting ECM turnover. Second, myofibroblasts are cap-
able of tonic contraction, and could therefore improve
structural integrity of the scar and increase mechanical
strength in the (sub)acute phase [43]. Particularly, the latter
is in concordance with the geometrical changes observed in
the present study.
The exact mechanism by which IPTVVI influenced
myofibroblast presence was not determined in the present
study. However, it is well known that LV pacing results in
considerable changes in LV contraction patterns, even in
the peri-infarct zone [25, 45], resulting in alterations in
regional stretch and loading conditions [17, 33, 36, 46].
Since mechanical tension is an important stimulus for
cardiac fibroblast to myofibroblast differentiation
[11, 15, 16, 26], it is likely that regional alterations in
myocardial stretch produced by IPTVVI stimulated resi-
dent fibroblasts to differentiate into myofibroblasts.
No change in circulating arterial plasma levels of the
inflammatory marker TNFa was found in IPTVVI vs. MI
control swine, at either 1 or 5 weeks after AMI, indicating
that the effect of pacing on release of these proteins in pigs
with infarcts was not discernible in the systemic circulation
even as early as 1 week post-AMI. Hence, altered myofi-
broblast presence within the infarcted area of IPTVVI
treated swine was likely the result of local effects on
myofibroblast recruitment and/or differentiation. As
myofibroblast migration and differentiation are initiated in
the early phase after MI, expression studies at 5-week
follow-up can by definition not identify which molecular
mechanisms underlie the higher myofibroblast presence.
Interestingly, the expression of the Fzd2 receptor, involved
in myofibroblast homeostasis [24], was increased in both
MI control and IPTVVI treated animals, which may have
served to maintain the myofibroblasts in the infarcted
region. It has previously been shown that activation of the
Fig. 3 Circulating levels of markers of extracellular matrix and inflammation. Markers for extracellular matrix and inflammation in arterial
plasma of five control (white bars) and five IPTVVI (gray bars) swine. Data are mean ± SEM; *P B 0.05 vs. MI control
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TGFb signaling pathway increases myofibroblast presence
[23], and therefore it is possible that this pathway was only
activated in the early phase of IPTVVI. This is also sug-
gested by a study in swine, in which continuous low dose
electrical stimulation within the infarct region, not only
resulted in higher numbers of myofibroblasts, but also in
elevated TGFb-R1 activity, when measured as early as one
week after onset of stimulation [32]. Expression of TGFb-
R1 and PAI-1, a measure for TGFb-R1 signaling were
downregulated in both the MI control and IPTVVI group as
compared to healthy control animals underlining the tran-
sient nature of the local inflammatory responses at the
molecular level to regional electrical stimulation. Although
in agreement with a previous study from our laboratory
[42], TGFb3 was upregulated in the infarcted tissue, this
was not altered by IPTVVI, making it unlikely that acti-
vation of the TGFb-pathway at five weeks follow-up
contributed to the increased presence of the myofibroblasts
in the IPTVVI treated animals.
In conclusion, the present study shows that 5 weeks of
IPTVVI, a regionally targeted non-pharmaceutical
approach that was safe (no arrhythmias and maintained
cardiac output), favorably influenced the infarct remodel-
ing process, likely by increasing myofibroblast content in
the infarct region. Thus, whereas MI control swine showed
a reduction in infarct mass over the 5-week follow-up
period, which was principally due to infarct thinning,
IPTVVI resulted in a reduction in infarct mass that was
principally due to a decrease in the number of infarcted LV
segments while infarct thinning was prevented. Histologi-
cal assessment revealed increased numbers of myofibrob-
lasts in the infarct zone. Taken together, these findings
suggest that IPT in the peri-infarct zone represents a novel
adjunctive therapy to favorably modulate infarct healing in
patients with acute myocardial infarction.
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